Posts by: Marisa Wexler, MS

Marisa Wexler, MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

April 27, 2020April 27, 2020

American Thoracic Society Publishes Guidelines to Help Clinicians Diagnose Sarcoidosis

News

The American Thoracic Society has published its first official guidelines for how best to detect and diagnosis sarcoidosis in clinical practice. The guidelines were published in the American Journal of Respiratory and ... Read more

March 30, 2020March 30, 2020

Pandemic Likely to Delay Results of Trial into Pulmonary Sarcoidosis Treatment

News

Results of a Phase 1b/2a clinical study evaluating ATYR1923 in people with pulmonary sarcoidosis are likely to be delayed due to the COVID-19 pandemic, its developer, aTyr Pharma, announced. ATYR1923 is ... Read more

March 16, 2020March 16, 2020

FDA Approves Ofev for Sarcoidosis and Other Interstitial Lung Diseases

News

Boehringer Ingelheim‘s Ofev (nintedanib) has been approved in the U.S. as the first treatment for chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype. This approval by the ... Read more

January 27, 2020January 27, 2020

aTyr and Kyorin Partner to Bring Potential Lung Sarcoidosis Treatment, ATYR1923, to Japan

News

aTyr Pharma announced a collaboration and license agreement with Kyorin Pharmaceutical to develop and commercialize ATYR1923, its potential disease-modifying treatment for those with interstitial lung diseases (ILDs), including pulmonary sarcoidosis, ... Read more

November 25, 2019November 25, 2019

Acthar Gel May Improve Sarcoidosis Symptoms, Real-world Study Shows

News

Acthar Gel (repository corticotropin injection, or RCI) can improve sarcoidosis symptoms, a real-world study shows. Titled “Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical ... Read more

November 18, 2019November 18, 2019

UCLA Launches Fundraising Effort for New Research Center for Sarcoidosis, Other Advanced Lung Diseases

News

The University of California, Los Angeles (UCLA) is launching a fundraising initiative to help improve treatment for advanced lung diseases, including sarcoidosis. The fundraising effort — called the Lung ... Read more

October 28, 2019October 28, 2019

Unusual Case of Tears in Heart Blood Vessels Found in Cardiac Sarcoidosis Patient

News

Tears in blood vessels of the heart can occur in people with cardiac sarcoidosis, a case report found, although the incidence of this complication appears to be low. The ... Read more

August 19, 2019August 19, 2019

Sarcoidosis Educational Event Set for Saturday at University of Cincinnati

News

An educational conference for people with sarcoidosis and those close to them will be held at the University of Cincinnati this Saturday, featuring doctors with expertise in this disease, presentations, and ... Read more

July 22, 2019July 22, 2019

Older Sarcoidosis Patients Have Worse Disease, Outcomes, Study Suggests

News

According to a new study comparing older and younger sarcoidosis patients, elderly people with sarcoidosis tend to have more severe disease and worse clinical outcomes. The study, “Elderly sarcoidosis: ... Read more

July 8, 2019July 8, 2019

Workplace Hazards Account for 30% of Sarcoidosis Cases, Study Suggests

News

Work-related hazards account for nearly 1 in 3 cases of sarcoidosis, and for at least 1 in 10 cases of other respiratory diseases, including asthma, chronic obstructive pulmonary disease ... Read more

Pin It on Pinterest